| 31 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
2021 |
| 32 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
2021 |
| 33 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
2021 |
| 34 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
2021 |
| 35 |
Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma |
2021 |
| 36 |
Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues |
2021 |
| 37 |
Micro-RNA 155 in non-Hodgkin lymphoma |
2021 |
| 38 |
Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients |
2021 |
| 39 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
2021 |
| 40 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
2021 |
